TransMedics TMDX
NASDAQ TMDX
$83.45 -0.62 (-0.74%)
At close: Sep 30, 2026 · 4:00 PM EDT

TransMedics (TMDX) Capital Leases (2026)

Updated

TransMedics (TMDX) recorded Capital Leases of $347.66 million in Q2 2026, up 1.1% from the prior quarter.

Analysis

TransMedics (TMDX) Capital Leases (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 TransMedics 2.89 Bn 1.00 Bn 113.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 347.66 Mn
Mar 31, 2026 343.83 Mn
API Access

TransMedics Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=TMDX&period=max&api_key=YOUR_API_KEY